###begin article-title 0
###xml 99 104 <span type="species:ncbi:9606">Human</span>
Computational identification and experimental validation of PPRE motifs in NHE1 and MnSOD genes of Human
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
Activation of PPARs has been reported to inhibit the proliferation of malignant cells from different lineages. They are involved in transcription regulation of genes upon activation by a ligand. The binding of PPARs to the promoter sequence either represses or activates the gene. Hence, PPARs represent promising targets for cancer treatment because of their anti-proliferative and pro-apoptotic activities. Here we computationally identified PPAR binding regions in NHE1 and MnSOD. We further validated the predictions in vitro.
###end p 2
###begin title 3
Results
###end title 3
###begin p 4
Our results computationally predicted the presence of 2 PPRE motifs in NHE1 and 3 PPRE motifs in MnSOD. We experimentally confirmed the true motifs and their regulation by PPAR.
###end p 4
###begin title 5
Conclusion
###end title 5
###begin p 6
Our results suggest that both NHE1 and MnSOD have PPRE binding motif in their upstream/promoter region and hence are regulated by PPAR upon ligand binding.
###end p 6
###begin title 7
Introduction
###end title 7
###begin p 8
###xml 180 181 180 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 508 509 508 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 637 638 637 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 438 448 <span type="species:ncbi:7227">Drosophila</span>
PPARs (Peroxisome proliferators activated Receptor) belong to the nuclear receptor super family and are ligand activated transcription factors, regulating a wide variety of genes [1]. Phylogenetic studies have shown that PPARs form a subfamily of the nuclear receptor superfamily, along with the receptors for thyroid hormone, retinoic acid (RA), vitamin D, ecdysone, and the orphan receptors Rev-ErbAa (5ear1;NR1D1) and E75 (NR1D3, from Drosophila), the two latter being the closest relatives of the PPARs [1]. PPARs play important role in lipid metabolism, cell differentiation and development, inflammation, cancer and demyelination [2].
###end p 8
###begin p 9
###xml 121 122 110 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 324 325 309 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 439 440 424 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 586 587 571 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 692 693 674 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 1099 1100 1074 1075 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 1214 1215 1181 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 1525 1526 1480 1481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 1851 1852 1794 1795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 2374 2383 2309 2318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro </italic>
###xml 2387 2394 2322 2329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 88 93 <span type="species:ncbi:10090">mouse</span>
###xml 95 100 <span type="species:ncbi:9606">human</span>
###xml 102 106 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
Three isoforms (alpha, beta and gamma) for PPAR have been identified so far in xenopus, mouse, human, rats and hamsters [3]. The isoforms exhibit a tissue specific expression pattern. The first isoform PPAR alpha is expressed in tissues that play a role in fatty acid catabolism such as liver, kidney, heart, and intestine [4]. This isoform is the first described receptor that is activated by peroxisome proliferators and hence the name [5]. The main function of this isoform is to regulate the genes encoding lipid metabolizing enzymes and proteins participating in lipid metabolism [4]. The second isoform is PPAR beta. This receptor is also called as FAAR (fatty acid activated receptor)[1]. This isoform is expressed mainly in the brain, skeletal muscle, skin, adipose tissue, gut, placenta and has a very broad expression pattern. Based on the cell proliferation and differentiation, the expression profile of this isoform varies. Both isoforms PPAR alpha and beta are involved in lipid utilization activities such as fatty acid oxidation, energy uncoupling reactions and response to fasting [1]. PPAR gamma has three alternatively spliced isoforms. PPAR gamma1 is virtually expressed in almost all tissues [6]. PPAR gamma2 is primarily expressed in adipose tissue while PPAR gamma3 is expressed in white adipose tissue, large intestine and macrophages. PPAR gamma regulates the lipid storage and insulin sensitivity reactions such as lipogenesis, adipocyte differentiation, adipocyte survival and adipokine secretion [1]. Activation of the peroxisome proliferator-activated receptor-gamma (PPARgamma) has been identified as an approach to induce differentiation and inhibit proliferation in a variety of cancer cells. Breast tissue, in particular, was found to express PPARgamma in amounts greater than those found in normal breast epithelium [7]. Moreover, activation of PPARgamma through cells' exposure to synthetic PPARgamma ligands such as proglitazone or rosiglitazone is shown to exert antitumor activity through cell growth inhibition and cellular differentiation. Activation of PPARs has been reported to inhibit the proliferation of malignant cells from different lineages such as liposarcoma, breast adenocarcinoma, prostate carcinoma, colorectal carcinoma, non-small cell lung carcinoma, pancreatic carcinoma bladder carcinoma, and gastric carcinoma both in vitro and in vivo.
###end p 9
###begin p 10
###xml 186 187 186 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 203 204 203 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 1048 1049 1037 1038 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1051 1053 1040 1042 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+ </sup>
###xml 1126 1128 1115 1117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 1129 1131 1118 1120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 1224 1226 1213 1215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 1227 1229 1216 1218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 1329 1331 1318 1320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 1386 1387 1375 1376 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1387 1390 1376 1379 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8226;- </sup>
###xml 1673 1675 1662 1664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 2217 2218 2198 2199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 2278 2279 2259 2260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
###xml 2099 2104 <span type="species:ncbi:9606">human</span>
Various studies have also shown that PPARs are involved in transcription regulation of genes upon activation by a ligand. The binding of PPARs to the promoter sequence either represses [8] or activates [9] the gene. Hence, PPARs represent promising targets for cancer treatment because of their anti-proliferative and pro-apoptotic activities. The PPAR alpha, beta, and gamma isoforms share a highly conserved DNA binding domain that recognizes specific DNA sequences known as Peroxisome Proliferator Response Elements (PPREs) (11). PPAR DNA-binding activity is modulated by Retinoic-X-Receptor (RXR). Upon ligand binding, PPAR translocates from cytoplasm to nucleus and forms heterodimer with RXR. PPAR/RXR complex then binds to PPRE composed of a Direct Repeat (DR) preferably spaced by one nucleotide (DR1) with a consensus sequence of AGGTCA-A-AGGTCA. It must be noted that there are DR2 motifs which are also recognized by PPAR that are preferably spaced by two nucleotide (DR2). Experimental evidences link upregulation of the pH regulator Na+/H+ exchanger 1 (NHE1) to the development and progression of carcinogenesis [10-15] and its down regulation to inhibition of cells' growth and enhanced apoptotic sensitivity [16,17]. It is also suggested that cancer cells are generally under reactive oxygen species (ROS) stress [18]. As mitochondrial respiration is the main source of O2*- generation in the cells, MnSOD (manganese superoxide dismutase) is of prime importance in maintaining cellular ROS balance and mitochondrial integrity in cells. This is specifically true for tumor cells which are constantly under ROS stress due to its increased metabolic processes [20]. Considering the abundance of PPARgamma receptor and elevated NHE1 expression in a variety of cancer cells including breast cancer and their absolute dependence on MnSOD it is of interest to explore PPARgamma agonists for selectively tailoring the expression of NHE1 and MnSOD. Therefore, we manually collected experimentally proven PPRE binding motifs from literature and arrived at a collection of 250 motifs. Search of human NHE1 and MnSOD promoter sequence against this collection predicted two putative DR2 PPRE motifs in NHE1 (Figure 1) and one DR1 PPRE and two DR2 PPRE motifs in MnSOD (Figure 2). We further investigated if PPARgamma binds to the promoter of NHE 1 and MnSOD genes at these PPRE motifs. Since these genes have not been identified as PPARgamma target genes in breast cancer cells, the results for the first time confirm regulation of NHE1 and MnSOD by PPARgamma.
###end p 10
###begin p 11
###xml 0 62 0 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Identification of putative PPREs in promoter of NHE1 and MnSOD</bold>
###xml 68 73 <span type="species:ncbi:9606">Human</span>
Identification of putative PPREs in promoter of NHE1 and MnSOD. (A) Human NHE1 promoter sequence from NCBI and Ensembl (Sequence IDs indicated). Alu element underlined, with putative PPREs italicized and bold. Transcriptional start site (T) and ATG translational start codon shown in figure. (B) We predicted two PPREs with PPARgamma binding efficiencies indicated.
###end p 11
###begin p 12
###xml 0 62 0 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Identification of putative PPREs in promoter of NHE1 and MnSOD</bold>
###xml 68 73 <span type="species:ncbi:9606">Human</span>
Identification of putative PPREs in promoter of NHE1 and MnSOD. (A) Human MnSOD promoter sequence from NCBI and Ensembl (Sequence IDs indicated). Alu element underlined, with putative PPREs italicized and bold. Transcriptional start site (G) and ATG translational start codon shown in figure. (B) We predicted PPRE1 and PPRE3 with PPARgamma binding efficiencies indicated.
###end p 12
###begin title 13
Methodology
###end title 13
###begin title 14
Collection of PPRE motifs from literature
###end title 14
###begin p 15
###xml 446 447 446 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S1">1</xref>
This collection contains 250 reported PPRE motifs from literature. Keywords "PPRE", "PPAR consensus sequences" "PPAR binding sequences" were used to search for literatures in pubmed and Google Scholar. The sequences reported only with experimental validation were added to this collection. For each PPRE data on its reported consensus, isoform specificity, in vivo and in vitro binding efficiencies and Pubmed IDs were collected (additional file 1).
###end p 15
###begin title 16
Promoter sequence extraction and motif identification
###end title 16
###begin p 17
###xml 545 546 545 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 606 607 606 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
###xml 415 420 <span type="species:ncbi:9606">human</span>
The promoter sequences (5 kb) upstream of the transcription start site from transcripts of NHE1 and MnSOD were downloaded from NCBI  using keywords NHE1 and MnSOD. The motif collection was searched/matched (string comparison) by a cgi-script against the extracted sequence of NHE1 and MnSOD, to check if there is presence of any of the motifs (string) in the upstream regions of the above gene sequences. Search of human NHE1 and MnSOD promoter sequences against this collection predicted/identified two putative DR2 PPRE motifs in NHE1 (Figure 1) and one DR1 PPRE and two DR2 PPRE motifs in MnSOD (Figure 2).
###end p 17
###begin p 18
The general DR1 and DR2 consensus are AGGTCA N AGGTCA (6-N-6) and AGGTCA NN AGGTCA (6-NN-6), respectively. Both the above patterns were matched against the collection, first by looking for the surrounding hexamers and then looking for the spacers i.e. one nucleotide or 2 nucleotides separation. Thus, the motifs for DR1 and DR2 are identified based on the number of 'N's that separate the two hexamer consensus pattern.
###end p 18
###begin p 19
These predicted motifs were experimentally validated as explained in the subsequent sections.
###end p 19
###begin title 20
Validation of identified patterns in NHE1 and MnSOD
###end title 20
###begin title 21
Reagents and antibodies
###end title 21
###begin p 22
###xml 690 692 683 685 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 91 97 <span type="species:ncbi:9913">bovine</span>
###xml 234 240 <span type="species:ncbi:9913">bovine</span>
###xml 262 267 <span type="species:ncbi:10090">mouse</span>
###xml 403 408 <span type="species:ncbi:10090">Mouse</span>
###xml 492 498 <span type="species:ncbi:9986">Rabbit</span>
###xml 580 584 <span type="species:ncbi:9925">goat</span>
###xml 590 595 <span type="species:ncbi:10090">mouse</span>
###xml 596 607 <span type="species:ncbi:3704">horseradish</span>
Roswell Park Memorial Institute (RPMI) 1640 medium, phosphate buffered saline (PBS), fetal bovine serum (FBS), L-glutamine and trypsin was purchased from Hyclone UT, USA. Pepstatin A, phenylmethanesulfonyl fluoride (PMSF), leupeptin, bovine serum albumin (BSA), mouse anti-beta-actin monoclonal antibody were supplied by Sigma-Aldrich LO, USA. Aprotinin was purchased from Applichem Darmstadt, Germany. Mouse anti-HuNHE1 monoclonal antibody was purchased from Chemicon International MA, USA. Rabbit anti-HuMnSOD monoclonal antibody was purchased from Upstate, NY, USA. Stabilized goat anti-mouse horseradish peroxidase (HRP) was obtained from Pierce IL, USA. The PPARgamma agonist, 15 d-PGJ2 was purchased from Alexis Biochemical CA, USA. 5'-biotinylated oligonucleotides for NoShift assay were synthesized by Proligo, Singapore.
###end p 22
###begin title 23
Cell lines and culture conditions
###end title 23
###begin p 24
###xml 331 332 325 326 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 242 248 <span type="species:ncbi:9913">bovine</span>
Human MCF-7, MDA-MB-231, and MDA-MB-468 breast carcinoma cells were obtained from the American Type Culture Collection (ATCC MD, USA). MCF-7, MDA-MB-231, and MDA-MB-468 cells were propagated and maintained in RPMI medium containing 10% fetal bovine serum (FBS), 2 mM L-glutamine, and 1 mM gentamicin sulfate at 37degreesC and 5% CO2. Cultures were replenished with fresh medium every 2 to 3 days and passage 1:3 when they reached 80% confluence.
###end p 24
###begin title 25
Western blot analysis
###end title 25
###begin p 26
###xml 154 155 154 155 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 157 158 157 158 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
Whole cell lysates were prepared with RIPA lysis buffer containing 10 mM Tris-HCL pH7.4, 30 mM NaCl, 1 mM EDTA, 1% Nonidet P-40, supplemented with 1 mM Na3VO4, 1 mug/ml leupeptin, 1 mug/ml pepstatin A, 1 mug/ml aprotinin and 1 mM PMSF before use. Protein concentration was determined for each sample and equal amounts of protein were warmed at 37degreesC in the water bath for NHE1 protein, boiled for 5 min for MnSOD, with 1 x SDS sample buffer and resolved by 8% (NHE1) or 12% (MnSOD) SDS-PAGE. Thereafter, proteins were transferred onto nitrocellulose membrane, blocked for 1 h at RT with 5% non-fat milk, and incubated overnight at 4degreesC with the primary antibody. After probing with secondary antibody for 1 h at 25degreesC, protein bands were detected by using the Supersignal West Pico Chemiluminescence (Pierce IL, USA). beta-actin antibody was used as a loading control.
###end p 26
###begin title 27
Reporter plasmid constructs
###end title 27
###begin p 28
###xml 308 313 <span type="species:ncbi:9606">human</span>
Chloramphenicol acetyltransferase (CAT) pUCSS-CAT reporter plasmid constructs: -1374/+16, -850/+16, and empty vector pUCSS-CAT were kindly provided by Dr. Alexey Kolyada, Dept of Medicine, Tufts University School of Medicine, Boston, USA (Kolyada et al., 1994). Full length and 5' deletion constructs of the human MnSOD promoter tagged to luciferase reporter gene were a gift from Dr. Daret K. St Clair, Graduate Center for Toxicology, University of Kentucky, USA (Xu et al., 2002).
###end p 28
###begin title 29
Chloramphenicol acetyltransferase (CAT) ELISA
###end title 29
###begin p 30
The levels of CAT protein were quantified using a CAT antigen capture enzyme-linked immunosorbent assay (ELISA) (Roche Molecular Biochemicals Mannheim Germany). All CAT quantitations were normalized to the protein concentration of the cell extract, as determined using the Coomasie Plus Protein Assay Reagent Kit (Pierce IL, USA).
###end p 30
###begin title 31
Luciferase reporter assays
###end title 31
###begin p 32
3 x PPRE promoter activity was assessed with a dual-luciferase assay kit (Promega WI, USA). Briefly, feeding medium was removed from the wells, washed once with 1x PBS, and lysed with ice-cold 100 mul of reporter lysis buffer. Ten microlitres of cell lysate was then added to 50 mul of luciferase substrate solution, following which 50 mul of stop & glow buffer was added for Renilla reading. Bioluminescence generated was measured using a Sirius luminometer (Berthold Technologies, Deutschland, Germany). The luminescence readings obtained were normalized to the protein content of the corresponding cell lysate. Activity was calculated by dividing luminescence readings expressed in relative light units (RLU)/renilla/mug total protein in 10 mul of cell extract used in the assay.
###end p 32
###begin title 33
NoShift transcription factor assay
###end title 33
###begin p 34
###xml 71 73 71 73 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 547 548 543 544 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Nuclear and cytosol fractions of MDA-MB-231 cells treated with 15 d-PGJ2 were prepared using the NE-PER Nuclear and cytoplasmic Extraction kit (Pierce IL, USA). The binding affinities of PPARgamma protein in nuclear extracts to three target PPREs on MnSOD promoter were determined with the NoShift transcriptional factor assay kit (Novagen Inc. NJ, USA). The oligonucleotide sequences (listed below) used for the three putative PPREs on MnSOD were first annealed in a PCR machine with 1x annealing buffer (1 mM TrisHCl pH 8, 50 mM NaCl, 10 mM MgCl2) and the annealed oligonucleotides then diluted to a final concentration of 100 ng/mul.
###end p 34
###begin p 35
HuMnSODPPRE-1 Sense 5'-Biotin-GTAACTTGGGACACAGGTCAATCGACTG-3'
###end p 35
###begin p 36
HuMnSODPPRE-1 Antisense 5'-Biotin-CAGTCGATTGACCTGTGTCCCAAGTTAC-3'
###end p 36
###begin p 37
HuMnSODPPRE-2 Sense 5'-Biotin-CACTTGAGGTCAGGCGTTCGAGACCA-3'
###end p 37
###begin p 38
HuMnSODPPRE-2 Antisense 5'-Biotin-TGGTCTCGAACGCCTGACCTCAAGTG-3'
###end p 38
###begin p 39
HuMnSODPPRE-3 Sense 5'-Biotin-TGGAATAGGTCCCAAGGTCGGCTTAC-3'
###end p 39
###begin p 40
HuMnSODPPRE-3 Antisense 5'-Biotin-GTAAGCCGACCTTGGGACCTATTCCA-3'
###end p 40
###begin p 41
###xml 1331 1332 1287 1288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 1332 1336 1288 1292 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">450 </sub>
###xml 858 869 <span type="species:ncbi:3704">horseradish</span>
###xml 903 909 <span type="species:ncbi:9986">rabbit</span>
For measurement of PPARgamma binding, each reaction mixture contained 5 mul of 4x NoShift Bind buffer, 1 mul of poly(dI-dC).poly(dI-dC) (0.01 U/mul in 100 mM KCl, 20 mM HEPES, pH 8.0), 1 mul of salmon sperm DNA (500 ng/mul in nuclease-free water), 1 mul of biotinylated 10-pmol/mul target DNA duplex, and 20 mug of nuclear lysate in a total reaction volume of 20 mul. After 30 min incubation on ice, 80 mul of 1x NoShift Bind buffer was added to each reaction mixture, and the resulting 100 mul was dispensed into one well of a freshly washed streptavidin plate and incubated for 1 h at 37degreesC. After this incubation period, plates were washed with 1x NoShift Bind buffer, the binding of PPARgamma was detected by incubation for 1 h at 37degreesC with 100 mul of anti-PPARgamma diluted 1:250 in NoShift antibody dilution buffer. After repeated washings, horseradish peroxidase (HRP)-conjugated anti-rabbit immunoglobulin G (IgG) was added (1:1000 dilution in NoShift antibody dilution buffer). After 30 min of incubation at 37degreesC, wells were washed thoroughly. Finally, 100 mul of room temperature TMB (tetramethylbenzidine) substrate was added and the wells were incubated for 10-30 min at room temperature in the dark until a blue color developed. The reaction was stopped by adding 100 mul of 1 M HCl to each well, and A450 was measured using Spectrofluoro Plus spectroflurometer (TECAN, Grodig, Austria).
###end p 41
###begin title 42
DNA transfections
###end title 42
###begin p 43
###xml 205 213 205 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla </italic>
Cells were transfected using CalPhost Mammalian transfection kit (BD Bioscience, CA, USA) for 15 h. Cells were then washed twice with PBS and culture media added for another 24 h. Co-transfection with the Renilla plasmid (Clontech, CA, USA) was used to assess transfection efficiency in dual-luciferase reporter assay (Promega, WI, USA).
###end p 43
###begin title 44
RNA isolation and mRNA determination by real-time PCR
###end title 44
###begin p 45
###xml 249 250 248 249 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 924 929 <span type="species:ncbi:9606">human</span>
###xml 989 994 <span type="species:ncbi:9606">human</span>
###xml 1004 1009 <span type="species:ncbi:9606">human</span>
Total RNA was isolated from cells by TRIZOL reagent (Invitrogen, CA, USA) as described by manufacturer's instructions with a DNAse treatment step incorporated into the protocol. Each RT reaction contains 2.5 mug of total RNA, 1x RT buffer, 5 mM MgCl2, 425 muM each of dNTPs, 2 muM random hexamers, 0.35 U/mul RNase inhibitor, 1.1 U/mul MultiScribetrade mark reverse transcriptase and made up to 10 mul with sterile water. RT reaction was carried out at 37degreesC for 1 h. 5 mul of the 10 mul cDNA reaction volume was used in realtime quantitative PCR using ABI PRISM 7500 (Applied Biosystems, CA, USA). Normalization was to either glyceraldehyde 3-phosphate dehydrogenase (GAPDH) or 18S RNA. Fluorescence was measured with the Sequence Detection Systems 2.0 software. PCR was performed in multiplex (both target and endogenous control co-amplified in the same reaction with distinct fluorescent dyes. Primers and probe for human glyceraldehyde-3-phosphate dehydrogenase (GAPDH), 18S RNA, human NHE1 and human MnSOD were purchased as kits from Applied Biosystems (Assays on Demand).
###end p 45
###begin title 46
Statistical analysis
###end title 46
###begin p 47
Statistical analysis was performed using paired Student's t-test. A p-value of less than 0.05 was considered significant.
###end p 47
###begin title 48
Results
###end title 48
###begin title 49
PPRE motif collection
###end title 49
###begin p 50
###xml 524 525 524 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S1">1</xref>
It is known that the general DR1 and DR2 consensus are AGGTCA N AGGTCA (6-N-6) and AGGTCA NN AGGTCA (6-NN-6), respectively. The determining factor for PPAR binding to the PPRE are the surrounding hexamers 1 and 2 (AGGTCA). The DR1 and DR2 motifs share the same hexamers and PPARs have also been reported to bind hexamers with DR2 spacers. Thus, for PPARs optimal spacer nucleotide is either 1 or 2. Out of the 413 PPRE DR1 motifs collected from literature the binding strengths were reported for 236 motifs (Additional file 1). These 236 motifs were used to match for both DR1 and DR2 sequences. Based on sequence match, we identified two putative PPREs in NHE1 and three putative PPREs in MnSOD promoter sequences.
###end p 50
###begin title 51
###xml 18 19 18 19 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</underline>
###xml 29 30 29 30 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</underline>
###xml 42 43 42 43 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</underline>
###xml 51 52 51 52 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</underline>
###xml 79 84 <span type="species:ncbi:9606">human</span>
Identification of Peroxisome Proliferator Response Elements (PPREs) within the human NHE1 and MnSOD promoters
###end title 51
###begin p 52
###xml 69 70 69 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 148 150 148 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 254 256 254 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 257 259 257 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 444 446 440 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 610 612 606 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2C</xref>
###xml 774 776 770 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 40 45 <span type="species:ncbi:9606">human</span>
###xml 369 374 <span type="species:ncbi:9606">human</span>
###xml 511 516 <span type="species:ncbi:9606">human</span>
###xml 574 579 <span type="species:ncbi:9606">human</span>
###xml 622 627 <span type="species:ncbi:9606">human</span>
We identified two putative PPREs in the human NHE1 promoter, (Figure 1). The first PPRE site (PPRE1) is within a primate-specific Alu element (Sq) [21], within which there is a cluster of four hexamers half-sites recognized by various nuclear receptors [22-25], termed as Alu receptor response element (AluRRE). Kumar et al. have previously shown in the context of the human myeloperoxidase gene, a DR2 element is also recognized by PPARgamma [24]. DR2 element, in both PPRE1 and PPRE2 are seen here within the human NHE1 promoter. We identified three putative PPREs in the human MnSOD promoter region (Figure 2C). In the human MnSOD promoter, PPRE1 is a DR1 element, while PPRE2 and PPRE3 are of the DR2 elements. Here, PPRE2 is within a primate-specific Alu element (Sx) [21].
###end p 52
###begin title 53
###xml 32 34 28 30 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
PPARgamma activation by 15 d-PGJ2 represses NHE1 mRNA and protein levels
###end title 53
###begin p 54
###xml 42 50 38 46 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15 d-PGJ</bold>
###xml 50 51 46 47 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 147 149 141 143 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 167 169 161 163 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 184 189 174 179 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12,14</sup>
###xml 193 194 183 184 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 245 246 235 236 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 328 329 314 315 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 482 483 467 468 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 543 545 528 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3A</xref>
###xml 606 608 591 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3B</xref>
###xml 613 615 598 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3C</xref>
To assess the effect of PPARgamma ligand (15 d-PGJ2) on NHE1 gene expression, MCF-7 and MDA-MB-231 cells were treated with 3 muM and 5 muM 15 d-PGJ2 for 24 h. 15 d-PGJ2 (15-deoxy-Delta12,14-PGJ2) is a metabolite of the eicosanoid prostaglandin J2, and is described as the most potent natural ligand for PPARgamma with reported Kds varying from 325 nM to 2.5 muM. As shown by real time quantification of mRNA level, exposure of both cell lines to increasing concentration of 15 d-PGJ2, led to a significant decrease in NHE1 mRNA levels (Figure 3A) dose-dependent decrease in NHE1 protein expression (Figure 3B and 3C).
###end p 54
###begin p 55
###xml 0 52 0 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Activation of PPAR&#947; induces NHE1 gene repression</bold>
###xml 125 127 119 121 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 456 458 450 452 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
Activation of PPARgamma induces NHE1 gene repression. (A) MCF-7 and MDA-MB-231 cells were exposed to 3 muM and 5 muM 15 d-PGJ2 for 24 h before NHE1 mRNA and protein levels were assessed as described in M&M. Relative NHE1 mRNA expression is expressed as percent of untreated control. Data shown is the mean of three experiments done in duplicate +/- SD. NHE1 protein expression in (B) MCF-7 and (C) MDA-MB-231 was analyzed by Western blot following 15 d-PGJ2 at doses indicated for 24 h. Equal loading ascertained using detection of beta-actin.
###end p 55
###begin title 56
###xml 32 34 28 30 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
PPARgamma activation by 15 d-PGJ2 represses MnSOD mRNA and protein levels
###end title 56
###begin p 57
###xml 123 124 123 124 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 287 289 287 289 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 303 305 303 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4A</xref>
###xml 486 488 486 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4B</xref>
###xml 493 495 493 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4C</xref>
###xml 34 39 <span type="species:ncbi:9606">human</span>
We investigated the regulation of human MnSOD mRNA and protein levels in two breast cancer cell lines treated with 15 d-PGJ2. Realtime-PCR analysis shows that relative MnSOD mRNA expressions in both MDA-MB-231 and MDA-MB-468 cells were significantly reduced when exposed varying 15 d-PGJ2 doses (Figure 4A). Western blot analysis corroborated this decrease in MnSOD mRNA levels with an observed dose-dependent decrease in MnSOD protein levels in MDA-MB-231 and MDA-MB-468 cells (Figure 4B and 4C).
###end p 57
###begin p 58
###xml 0 55 0 51 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Activation of PPAR&#947; represses MnSOD gene repression</bold>
###xml 134 136 128 130 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 473 475 467 469 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
Activation of PPARgamma represses MnSOD gene repression. (A) MDA-MB-231 and MDA-MB-468 cells were exposed to 5 muM and 10 muM 15 d-PGJ2 for 24 h before MnSOD mRNA and protein levels were assessed as described in M&M. Relative MnSOD mRNA expression is expressed as percent of untreated control. Data shown is the mean of three experiments done in duplicate +/- SD. MnSOD protein expression in (B) MDA-MB-231 and (C) MDA-MB-468 was analyzed by Western blot following 15 d-PGJ2 at doses indicated for 24 h. Equal loading ascertained using detection of beta-actin
###end p 58
###begin title 59
Experimental evidence for PPRESearch-derived prediction for PPARgamma binding site in NHE1 promoter
###end title 59
###begin p 60
###xml 322 324 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5A</xref>
###xml 382 384 374 376 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 532 534 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5B</xref>
###xml 47 52 <span type="species:ncbi:9606">human</span>
To determine which of the two PPREs within the human NHE1 is the true PPARgamma binding site, we transfected MCF-7 breast cancer cells with a full length NHE1 promoter construct (containing both PPRE1 and PPRE2) compared to a parallel set up transfected with a 5' deletion of the full length (only contains PPRE2) (Figure 5A). Activation of PPARgamma by its natural ligand, 15 d-PGJ2 decreased NHE1 promoter activity only when cells were transfected with the full length NHE1 promoter construct but not when PPRE1 is absent (Figure 5B). Our results therefore demonstrate that NHE1 is a PPARgamma target gene. We also narrowed the bonafide PPARgamma binding site to PPRE1, thereby providing experimental evidence for predicted PPRE motifs in the upstream region of NHE1.
###end p 60
###begin p 61
###xml 0 47 0 43 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#947; binds to PPRE1 in human NHE1 promoter</bold>
###xml 448 450 442 444 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 586 592 580 586 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">405 nm</sub>
###xml 28 33 <span type="species:ncbi:9606">human</span>
###xml 94 99 <span type="species:ncbi:9606">human</span>
###xml 276 281 <span type="species:ncbi:9606">human</span>
PPARgamma binds to PPRE1 in human NHE1 promoter. (A) Schematic representations of full length human NHE1 promoter construct (-1374/+16) and a 5'-deletion construct (-850/+16) with location of PPRE1 and PPRE2 indicated. (B) MCF-7 cells transiently transfected with full length human NHE1 promoter construct (-1374/+16) and a 5'-deletion derivative of the full length lacking the PPRE site (-850/+16). Cells were treated with 3 muM and 5 muM 15 d-PGJ2 for 16 h. CAT-ELISA activity measured following manufacturer's instructions. NHE1 promoter activities were calculated as CAT activity (A405 nm)/mug total protein and expressed as absorbance/mug total protein. Data represents the average +/- SD of two experiments done in duplicate.
###end p 61
###begin title 62
###xml 86 91 <span type="species:ncbi:9606">human</span>
Experimental evidence for PPRESearch-derived prediction for PPARgamma binding site in human MnSOD promoter
###end title 62
###begin p 63
###xml 310 312 306 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6A</xref>
###xml 410 412 406 408 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 480 482 476 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6B</xref>
###xml 680 682 676 678 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 721 723 717 719 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 797 799 789 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6B</xref>
###xml 967 969 955 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6C</xref>
###xml 1438 1440 1414 1416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6C</xref>
###xml 49 54 <span type="species:ncbi:9606">human</span>
###xml 136 141 <span type="species:ncbi:9606">human</span>
###xml 736 741 <span type="species:ncbi:9606">human</span>
###xml 1052 1057 <span type="species:ncbi:9606">human</span>
To determine which of the three PPREs within the human MnSOD is the true PPARgamma binding site, we transfected MDA-MB-231 cells with a human MnSOD promoter construct (-3400 to +24, containing PPRE1, PPRE2, and PPRE3) and a 5' deletion construct (-1605 to +24) that lacks PPRE1 but has PPRE2 and PPRE3 (Figure 6A). Our results show both full length construct and the 5' deletion construct responded to 15 d-PGJ2 treatment in a dose-dependent decrease in promoter activity (Figure 6B). This seems to suggest that the bonafide PPRE would be either PPRE2 or PPRE3. Interestingly, a further 5' deletion construct (-555 to +24) that lacks all three PPREs did not decrease with 15 d-PGJ2 treatment, which suggests that 15 d-PGJ2 treatment on human MnSOD promoter activity is PPARgamma-dependent (Figure 6B). To determine if PPRE2 or PPRE3 is the bonafide PPARgamma binding site, using a NoShift assay with 5' biotinylated oligonucleotides for each of the two PPREs,(Figure 6C), we conclusively show that PPRE3 is indeed the PPARgamma binding site within the human MnSOD promoter region, providing experimental proof for our prediction. Interestingly, PPRE3 also had the strongest predicted binding efficiency of 0.89 based on literature. More importantly, PPRE2 which was not predicted by PPRE (but was added as it was Alu element (Sx)) to bind PPARgamma, our DNA binding assay indeed shows no significant binding by PPARgamma to PPRE2 (Figure 6C).
###end p 63
###begin p 64
###xml 0 48 0 44 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR&#947; binds to PPRE3 in human MnSOD promoter</bold>
###xml 431 433 425 427 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 453 461 447 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla </italic>
###xml 28 33 <span type="species:ncbi:9606">human</span>
###xml 95 100 <span type="species:ncbi:9606">human</span>
PPARgamma binds to PPRE3 in human MnSOD promoter. (A) Schematic representations of full length human MnSOD promoter construct (-3400 to +24 pGL3) and two 5'-deletion constructs (-1605 to +24 pGL3; -555 to +24 pGL3) with location of PPRE1, PPRE2 and PPRE3 indicated. (B) Luciferase assay of MnSOD promoter activity in MDA-MB-231 transiently transfected with full length and 5'-deletion derivatives followed 5 muM and 10 muM 15 d-PGJ2 treatment for 16 h. Renilla plasmid was cotransfected to assess transfection efficiency. Results are expressed as RLU/renilla/mug total protein. Data represents the average +/-SD of two experiments done in duplicate. (C) No-shift DNA binding assay to assess DNA binding activity of PPARgamma at PPRE2 and PPRE3 of MnSOD promoter as described in M&M. Results are expressed as absorbance readings at 450 nm. Data represents the average +/- SD of two experiments done in duplicate.
###end p 64
###begin title 65
Discussion
###end title 65
###begin p 66
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 411 412 411 412 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</underline>
###xml 422 423 422 423 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</underline>
###xml 435 436 435 436 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</underline>
###xml 445 446 445 446 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</underline>
###xml 454 455 454 455 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</underline>
###xml 619 621 615 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 154 159 <span type="species:ncbi:9606">women</span>
###xml 293 301 <span type="species:ncbi:9606">patients</span>
Breast cancer is the third most common cancer globally and accounts for the highest morbidity and mortality. It is the second highest occurring cancer in women and one of the leading causes of death [26]. Although anti-estrogens have provided an effective endocrine therapy, a large number of patients acquiring resistance to these drugs pose a significant problem. Recently, a new approach using activators of peroxisome proliferator-activated receptor gamma (PPARgamma) to inhibit proliferation and increase cell death in breast cancer cell lines has given hope to the development of a new class of anticancer drugs [27]. Interestingly, tumor breast tissue expresses PPARgamma in amounts greater than normal breast epithelium, suggesting for a novel therapeutic approach for ligand-activated PPARgamma as an anti-tumor agent in differentiation-based breast cancer therapy.
###end p 66
###begin p 67
###xml 85 86 85 86 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 111 113 111 113 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i </sub>
###xml 154 156 154 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+ </sup>
###xml 165 166 165 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 168 170 168 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+ </sup>
###xml 370 372 370 372 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i </sub>
###xml 619 621 619 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 736 737 736 737 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 738 740 738 740 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 829 831 829 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 832 834 832 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 613 617 <span type="species:ncbi:10090">mice</span>
Normal functioning of cell metabolism occurs within a restricted intracellular pH (pHi) range. Regulation of pHi is accomplished via active extrusion of H+ by the Na+/H+ Exchangers (NHEs), a membrane antiporter expressed in a variety of cell types. The NHE family consists of ten isoforms, NHE1 to NHE10. Interestingly, apart from its role as a principal regulator of pHi and cell volume, the ubiquitously expressed NHE1 has been implicated in cell proliferation and transformation. Conversely, tumor cells deficient in NHE1 either fail to grow or show severely retarded growth when implanted in immuno-deficient mice [12]. More recently, we showed that down regulation of NHE1 expression by direct silencing of the gene expression or H2O2 treatment leads to cells' growth arrest and sensitization to etoposide or staurosporine [16,17].
###end p 67
###begin p 68
###xml 190 192 190 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 193 195 193 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 609 611 609 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 679 681 679 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 760 762 756 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 386 390 <span type="species:ncbi:10090">mice</span>
###xml 697 702 <span type="species:ncbi:10090">mouse</span>
###xml 808 813 <span type="species:ncbi:9606">human</span>
Development of breast cancer has also been correlated to oxidative stress, brought about by alterations to the delicate balance between reactive oxygen species (ROS) and oxidative defenses [28,29] ROS stress seems to render cancer cells more dependent on MnSOD to protect them by maintaining cellular ROS balance. The importance of MnSOD became clearer when genetic knockout studies in mice indicate that MnSOD, but not other SODs, is essential for cell survival. Several recent studies reported that forced suppression of MnSOD expression by siRNA leads to decrease in breast cancer cells invasive property [30]and to sensitization of ovarian cancer cells to anti-cancer drugs [31]. Although the mouse MnSOD gene has been shown to be a PPARgamma target gene [32], a direct association between PPARgamma and human MnSOD from tumor cells' perspective has not been shown.
###end p 68
###begin p 69
###xml 494 496 490 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 619 624 <span type="species:ncbi:9606">human</span>
###xml 720 725 <span type="species:ncbi:10090">mouse</span>
###xml 873 878 <span type="species:ncbi:9606">human</span>
Taken together, our results suggest that NHE1 and MnSOD have PPRE binding motifs of high affinity. This confirms that these genes can be downregulated by PPARgamma in presence of a ligand. Since, downregulation of NHE1 inhibits proliferation and increases cell death in breast cancer cell lines, the presented data provides new direction for development of a new class of anticancer drugs. Concurrently, downregulaion of MnSOD expression is reported to decrease cancer cells invasive property [30] and sensitizes cancer cells to anti-cancer drugs. Thus, the presented data suggests that PPARgamma can regulate MnSOD in human cell linesPPARgamma has been found to regulate MnSOD transcription by binding to a PPRE on the mouse MnSOD promoter region. This report for the first time suggests PPARgamma activation and its involvement in downregulating MnSOD gene expression in human.
###end p 69
###begin title 70
Competing interests
###end title 70
###begin p 71
The authors declare that they have no competing interests.
###end p 71
###begin title 72
Authors' contributions
###end title 72
###begin p 73
G.V., S.M.K., and A.P.K conceived the idea of developing a PPRE motifs database. G.V. collected all motifs, constructed the database and wrote CGI-script for searching motifs. S.M.K. supervised the construction of the PPRE motifs database. A.P.K, M.V.C, and S.P. designed and supervised all experimental data. A.P.K. and S.Y.L performed validation experiments on NHE1 and MnSOD. S.M.K., G.V., A.P.K., and M.V.C. wrote the manuscript.
###end p 73
###begin title 74
Note
###end title 74
###begin p 75
###xml 61 80 61 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BMC Bioinformatics </italic>
Other papers from the meeting have been published as part of BMC Bioinformatics Volume 10 Supplement 15, 2009: Eighth International Conference on Bioinformatics (InCoB2009): Bioinformatics, available online at .
###end p 75
###begin title 76
Supplementary Material
###end title 76
###begin title 77
Additional file 1
###end title 77
###begin p 78
List of DR1 and DR2 motifs from literature.
###end p 78
###begin p 79
Click here for file
###end p 79
###begin title 80
Acknowledgements
###end title 80
###begin p 81
###xml 462 467 <span type="species:ncbi:9606">human</span>
This work was supported by grant R-183-000-204-213 from the National Medical Research Council, Singapore to MVC, SP and APK. The authors also thank Dr. Alexey Kolyada, Dept of Medicine, Tufts University School of Medicine, Boston, USA for providing the pUCSS-CAT NHE1 reporter plasmid constructs: -1374/+16, -850/+16, and empty vector pUCSS-CAT and Dr. Daret K. St Clair, Graduate Center for Toxicology, University of Kentucky, USA for providing the full length human MnSOD promoter construct and the various 5' deletions derivatives tagged to a luciferase reporter (pGL3 vector).
###end p 81
###begin p 82
###xml 43 56 43 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BMC Genomics </italic>
This article has been published as part of BMC Genomics Volume 10 Supplement 3, 2009: Eighth International Conference on Bioinformatics (InCoB2009): Computational Biology. The full contents of the supplement are available online at .
###end p 82
###begin article-title 83
International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors
###end article-title 83
###begin article-title 84
The mechanisms of action of PPARs
###end article-title 84
###begin article-title 85
Peroxisome proliferator-activated receptors: nuclear control of metabolism
###end article-title 85
###begin article-title 86
From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions
###end article-title 86
###begin article-title 87
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
###end article-title 87
###begin article-title 88
###xml 27 32 <span type="species:ncbi:10090">mouse</span>
Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms
###end article-title 88
###begin article-title 89
Activation of peroxisome proliferator-activated receptor gamma by a novel synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest and apoptosis in breast cancer cells
###end article-title 89
###begin article-title 90
The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation
###end article-title 90
###begin article-title 91
PPAR gamma is required for placental, cardiac, and adipose tissue development
###end article-title 91
###begin article-title 92
Hormonal regulation, pharmacology, and membrane sorting of vertebrate Na+/H+ exchanger isoforms
###end article-title 92
###begin article-title 93
Molecular physiology of vertebrate Na+/H+ exchangers
###end article-title 93
###begin article-title 94
Requirement of the Na+/H+ exchanger for tumor growth
###end article-title 94
###begin article-title 95
Na+/H+ exchanger-dependent intracellular alkalinization is an early event in malignant transformation and plays an essential role in the development of subsequent transformation-associated phenotypes
###end article-title 95
###begin article-title 96
pHi, aerobic glycolysis and vascular endothelial growth factor in tumour growth
###end article-title 96
###begin article-title 97
###xml 27 33 <span type="species:ncbi:10090">murine</span>
Targeted disruption of the murine Nhe1 locus induces ataxia, growth retardation, and seizures
###end article-title 97
###begin article-title 98
Reactive oxygen species-mediated regulation of the Na+-H+ exchanger 1 gene expression connects intracellular redox status with cells' sensitivity to death triggers
###end article-title 98
###begin article-title 99
Oxidative repression of NHE1 gene expression involves iron-mediated caspase activity
###end article-title 99
###begin article-title 100
Intrinsic oxidative stress in cancer cells: a biochemical basis for therapeutic selectivity
###end article-title 100
###begin article-title 101
###xml 84 89 <span type="species:ncbi:9606">human</span>
Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer
###end article-title 101
###begin article-title 102
Mitochondria, manganese superoxide dismutase, and cancer
###end article-title 102
###begin article-title 103
###xml 31 36 <span type="species:ncbi:9606">human</span>
Reconstruction and analysis of human Alu genes
###end article-title 103
###begin article-title 104
An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element
###end article-title 104
###begin article-title 105
The consensus sequence of a major Alu subfamily contains a functional retinoic acid response element
###end article-title 105
###begin article-title 106
Peroxisome proliferator-activated receptor gamma ligands regulate myeloperoxidase expression in macrophages by an estrogen-dependent mechanism involving the -463GA promoter polymorphism
###end article-title 106
###begin article-title 107
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human myeloperoxidase gene is regulated by LXR and PPARalpha ligands
###end article-title 107
###begin article-title 108
###xml 77 82 <span type="species:ncbi:9606">Human</span>
Expression of Mn-Superoxide Dismutase Gene in Nontumorigenic and Tumorigenic Human Mammary Epithelial Cells
###end article-title 108
###begin article-title 109
###xml 108 113 <span type="species:ncbi:9606">human</span>
Novel therapeutic approach: ligands for PPARgamma and retinoid receptors induce apoptosis in bcl-2-positive human breast cancer cells
###end article-title 109
###begin article-title 110
Suppression of tumor metastasis by maganese superoxide dismutase is associated with reduced tumorigenicity and elevated fibronectin
###end article-title 110
###begin article-title 111
Oxidants and antioxidants in breast cancer
###end article-title 111
###begin article-title 112
###xml 76 81 <span type="species:ncbi:9606">human</span>
Role of manganese superoxide dismutase on growth and invasive properties of human estrogen-independent breast cancer cells
###end article-title 112
###begin article-title 113
Chemosensitisation by manganese superoxide dismutase inhibition is caspase-9 dependent and involves extracellular signal-regulated kinase 1//2
###end article-title 113
###begin article-title 114
Cardiac peroxisome proliferator-activated receptor gamma is essential in protecting cardiomyocytes from oxidative damage
###end article-title 114

